Nate

[Nate @BiotechNate]

@SerranoReyMiami @himshouse Perfect case of ChatGPT hallucinating. Please read the actual SEC form it's not that difficult. It clearly states it was not done under 10b5-1 and was an informative sale.

[Nate @BiotechNate]

@ManOnThePen What’s the source for 503b starting to compound?

[Nate @BiotechNate]

@EgorBezel @A_May_MD Can you explain this? How does this work.

[Nate @BiotechNate]

@RobertKennedyJr Excited about your leadership. Wanted to ask if you had a view of GLP-1 drug compounding during the FDA obesity drug shortage. It’s believed millions of Americans are getting unauthorized “copycats” of obesity drugs like Ozempic. The API comes from China.

[Nate @BiotechNate]

@seedy19tron was this deck updated recently?

[Nate @BiotechNate]

@CEOCorbus How much peptide reactor volume is that? 1.8 tons = 1800 kg; assuming 1kg:1L reactor volume, is finding 1800 Ls of peptide capacity that hard? Or is the proportion much lower?

[Nate @BiotechNate]

@EtihadHelp Thanks! Sent a DM.

[Nate @BiotechNate]

@EtihadHelp my grandpa died and his funeral was a few days after my flight. I requested a bereavement refund and submitted a death certificate, my passport, an obituary, my birth certificate and they have not processed the refund for 5 months. Pls help, it’s been a nightmare.

[Nate @BiotechNate]

@semodough I want to know what @MaxJacobsCFA thinks.

[Nate @BiotechNate]

@semodough @0xPasserby @Biohazard3737 they do do own Aimmune…

[Nate @BiotechNate]

@paras_biotech Overenrolled trials might have more unmet need and greater regulatory leniency. A ton of other conflating factors.

[Nate @BiotechNate]

@LokiManagement @bradloncar Continuous readouts in 20+ indications across 15+ tumor types including hundreds of non-label enhancing studies have cemented Keytruda in the minds of oncs nationwide.

[thomas the divorced trader @tumtonks]

@chamath @GavinNewsom Chamath—my 8 year old son is a huge fan of SPACs. He drew this for you! He would love to know what you think.

[Nate @BiotechNate]

@BearishBullsCEO $AGEN

[Nate @BiotechNate]

@VPrasadMDMPH @sciencescanner Was the 0.9% just a typo? The 0.9 mo is a ~18% improvement in PFS (entirely agree with the sentiment that it’s not clinically meaningful to the unmet needs in these patients)

[Nate @BiotechNate]

@CaughtChasing Sold EOD yesterday, it was 50% of my positions 😭

[Nate @BiotechNate]

@semodough How do we feel about the safety data 😕

[Nate @BiotechNate]

@adamfeuerstein what happen to fundamentals? I thought institutional investors were the market movers not Robinhood day traders ☹️

[Nate @BiotechNate]

@AAMC_MCAT it’s over. I’m already getting the targeted ads for Caribbean medical school